scholarly article | Q13442814 |
P50 | author | Emily Chew | Q24266614 |
Philip J Rosenfeld | Q114427406 | ||
Susan B Bressler | Q114739669 | ||
Age-Related Eye Disease Study 2 Research Group | Q117242065 | ||
Elvira Agrón | Q83234331 | ||
Traci E Clemons | Q92993074 | ||
P2093 | author name string | Nancy Huynh | |
Benjamin P Nicholson | |||
P2860 | cites work | A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8 | Q24544001 |
A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9 | Q24546140 | ||
Lutein + Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular Degeneration | Q28290149 | ||
Prevalence of age-related macular degeneration in the United States | Q29614964 | ||
Ranibizumab for neovascular age-related macular degeneration | Q29617549 | ||
Is there an association between cataract surgery and age-related macular degeneration? Data from three population-based studies | Q30800516 | ||
Lutein/zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no. 4. | Q34343037 | ||
Risk of advanced age-related macular degeneration after cataract surgery in the Age-Related Eye Disease Study: AREDS report 25. | Q34491990 | ||
Visual acuity outcomes after cataract surgery in patients with age-related macular degeneration: age-related eye disease study report no. 27 | Q34493282 | ||
The association of cataract and cataract surgery with the long-term incidence of age-related maculopathy: the Beaver Dam eye study | Q34528853 | ||
The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17 | Q34653094 | ||
The relationship of cataract and cataract extraction to age-related macular degeneration: the Beaver Dam Eye Study | Q36140110 | ||
The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1) | Q36360812 | ||
Methods and reproducibility of grading optimized digital color fundus photographs in the Age-Related Eye Disease Study 2 (AREDS2 Report Number 2) | Q36996217 | ||
Progression of age-related macular degeneration after cataract surgery | Q43245378 | ||
Cataract surgery in high-risk age-related macular degeneration: a randomized controlled trial. | Q43287122 | ||
Risk of fractures following cataract surgery in Medicare beneficiaries | Q45787525 | ||
Depression, visual acuity, comorbidity, and disability associated with age-related macular degeneration. | Q45983717 | ||
Prevalence of cataract and pseudophakia/aphakia among adults in the United States | Q46196467 | ||
Ranibizumab for predominantly classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR results | Q46940817 | ||
Cataract surgery and the 10-year incidence of age-related maculopathy: the Blue Mountains Eye Study. | Q50476310 | ||
Long-term visual outcome after cataract surgery: comparison of healthy eyes and eyes with age-related macular degeneration. | Q50975726 | ||
Age-related macular degeneration after extracapsular cataract extraction with intraocular lens implantation | Q71692991 | ||
Cataract surgery is associated with a higher rate of photodynamic therapy for age-related macular degeneration | Q79707760 | ||
Is pseudophakia a risk factor for neovascular age-related macular degeneration? | Q80050199 | ||
Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1 | Q80553646 | ||
Phacoemulsification does not induce neovascular age-related macular degeneration | Q80836853 | ||
Cataract surgery in ranibizumab-treated patients with neovascular age-related macular degeneration from the phase 3 ANCHOR and MARINA trials | Q84601830 | ||
P433 | issue | 6 | |
P921 | main subject | eye disease | Q3041498 |
macular degeneration | Q27429789 | ||
P304 | page(s) | 1229-1236 | |
P577 | publication date | 2014-03-07 | |
P1433 | published in | Ophthalmology | Q7098109 |
P1476 | title | Visual acuity after cataract surgery in patients with age-related macular degeneration: age-related eye disease study 2 report number 5. | |
P478 | volume | 121 |
Q92200968 | A case report detailing use of a new intraocular lens with advanced technology, designed specifically for patients with center-involving macular disorders |
Q35544915 | Cataract surgery and age-related macular degeneration. An evidence-based update. |
Q51723541 | Cataract surgery in patients with neovascular age-related macular degeneration. |
Q36504075 | Cost-Utility Analyses of Cataract Surgery in Advanced Age-Related Macular Degeneration |
Q58731323 | Effect of Phacoemulsification on Visual Acuity and Macular Morphology in Patients with Wet Age-Related Macular Degeneration |
Q64093434 | First-Year Outcomes of Cataract Surgery Combined with Intravitreal Ranibizumab Injection in Wet Age-Related Macular Degeneration |
Q34597977 | Metamorphopsia and letter recognition |
Q42367908 | MicroRNAs: new players in cataract |
Q55919856 | Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease |
Q89958068 | Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease |
Q90307768 | Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease |
Q57689012 | Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease |
Q93360900 | Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease |
Q88615813 | Supplementation with macular carotenoids improves visual performance of transgenic mice |
Q38261108 | The impact of cataract surgery on AMD development and progression. |
Q50522077 | [Multifocal electroretinography for therapeutic effect evaluation of intravitreal injection Lucentis for wet age-related macular degeneration]. |
Search more.